Clinical Trial Update: Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fluticasone propionate multidose inhaler to fluticasone propionate/salmeterol inhaler in asthma was completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Propionate Multidose Dry Powder Inhaler (fluticasone propionate)
• Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (fluticasone propionate/salmeterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-03-18